Use of immunomodulatory therapy (other than interferon) for the treatment of chronic hepatitis B virus infection

被引:18
作者
Lau, GKK [1 ]
机构
[1] Queen Mary Hosp, Univ Dept Med, Div Gastroenterol & Hepatol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1046/j.1440-1746.2000.02102.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic hepatitis B virus (HBV) infection is a major health threat in Asia. In order to design a better therapeutic regimen, the underlyng mechanism of HBV viral persistence must be understood. Immunological studies have found that impaired HBV virus-specific T cell reactivity is the major cause of chronic infection, whereas strong and multispecific T cell responses to HBV are associated with longterm control, but nor elimination of the virus. Furthermore, in the serological clearance of hepatitis B surface antigen (HBsAg) in allogeneic haematopoietic cell transplantation, HBsAg seroconversion is associated with activation of the donor's hepatitis B core antigen-specific CD4(+) T lymphocytes. This suggests that the donor's hepatitis B core antigen-specific CD4(+) T cells provide 'intermolecular T cell help' for the HBsAg seroconversion. These findings are relevant to the future development of therapeutic vaccines or DNA vaccine as immunotherapy for chronic hepatitis B. Apart from interferon-alpha, thymosin alpha 1 (T alpha 1) has been investigated for treatment of chronic hepatitis B. Meta-analysis of 4 randomized controlled studies investigating the safety and efficacy of T alpha 1 monotherapy for the treatment of chronic hepatitis B showed that: 6 months treatment with T alpha 1 (1.6 mg twice weekly) almost doubles the sustained response rate (36%) compared with controls (19%; P=0.04). However, more specific immunological approaches are being developed; notably, hepatitis B core antigen-based therapeutic vaccine was found to induce T cell proliferative responses in chronically infected hepatitis B patients to the T helper epitope included in the construct. However, the cytokine profile observed suggested the induction of a T helper 0/T helper 2 CD4(+) T cell response rather than T helper 1 response. Thus, its combination with interferon-gamma or interleukin-12, which might reverse the CD4(+) T cell response, should be considered. In the future, it is likely that different types of combination therapy may have to be tailor-made for chronic HBV infection with different virological and immunological profiles and different degrees of liver damage. (C) 2000 Blackwell Science Asia Pty Ltd.
引用
收藏
页码:E46 / E52
页数:7
相关论文
共 63 条
  • [1] Ahuja SS, 1998, J IMMUNOL, V161, P868
  • [2] Andreone P, 1996, HEPATOLOGY, V24, P774
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
    Boni, C
    Bertoletti, A
    Penna, A
    Cavalli, A
    Pilli, M
    Urbani, S
    Scognamiglio, P
    Boehme, R
    Panebianco, R
    Fiaccadori, F
    Ferrari, C
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) : 968 - 975
  • [5] Hepatitis B associated liver failure following bone marrow transplantation
    Caselitz, M
    Link, H
    Hein, R
    Maschek, H
    Boker, K
    Poliwoda, H
    Manns, MP
    [J]. JOURNAL OF HEPATOLOGY, 1997, 27 (03) : 572 - 577
  • [6] CELIS E, 1988, J IMMUNOL, V140, P1808
  • [7] CHANGING OF HEPATITIS-B VIRUS MARKERS IN PATIENTS WITH BONE-MARROW TRANSPLANTATION
    CHEN, PM
    FAN, S
    LIU, CJ
    HSIEH, RK
    LIU, JH
    CHUANG, MW
    LIU, RS
    TZENG, CH
    [J]. TRANSPLANTATION, 1990, 49 (04) : 708 - 713
  • [8] Efficacy of thymosin α1 in patients with chronic hepatitis B:: A randomized, controlled trial
    Chien, RN
    Liaw, YF
    Chen, TC
    Yeh, CT
    Sheen, IS
    [J]. HEPATOLOGY, 1998, 27 (05) : 1383 - 1387
  • [9] HEPATITIS-B VIRUS IMMUNOPATHOGENESIS
    CHISARI, FV
    FERRARI, C
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 : 29 - 60
  • [10] Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2
    Chow, YH
    Huang, WL
    Chi, WK
    Chu, YD
    Tao, MH
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (01) : 169 - 178